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Covalent fusion with capsid proteins or the introduction of non-specific tags are among common methods used. [14] [15] [16] Engineered protein boxes face similar issues, while their functional fitness strictly depends on the programmability of assembly, which remains inferior to that of native viruses. 17 An alternative can be provided by a molecular class demonstrating a superior (or better understood) programmability that is intrinsically compatible with non-covalent protein encapsulation. A strategy to realize this is to evert the gene delivery of protein-built boxes into the protein delivery of DNA-built boxes -the concept that we introduce herein as an inside-out or everted virus topology.
Results and Discussion
The topology adapts the principles of DNA origami using the M13mp18 genomic DNA as a scaffold strand. 18 Since their inception the principles prove versatile for programming DNA forms of virtually any complexity, 19, 20 while interest in intracellular applications has been steadily increasing. [20] [21] [22] As DNA does not typically traverse cellular membranes, origami structures are being attempted as conjugates with proteins targeting cellular receptors, 23, 24 complexes with hydrophobic drugs 25 or as cargo in viruses 26 and lipid envelops. 27 Unlike linear or plasmid DNA, 3D-folded origami constructs such as icosahedral cages may be used to host fluorescent cargo for in vivo imaging, 28 intercalate anticancer drugs for cancer targeting, 29 enable light-triggered release of bioactives 30 or geometrically adapt to tailor protein encapsulation. 31 The delivery of folded proteins is an altogether different proposition entailing the challenges of controlled and functional delivery, which may not be achieved using structures as fixed and porous as icosahedral cages. For these reasons, we chose the topology of a three-dimensional cube, in which one face serves as a lid (Table S1 and Fig S1 in Supporting Information).
The design is an equilateral 25-nm hollow box with characteristic 2-, 3-and 4-fold symmetries, which renders it a [3, 4]-fold symmetry topology (Fig 1A & S2) . The cube is held together by 4 single-strand staples that lock lid and bottom faces orthogonally via one side (Table S1 , Fig   S1-S3 ). 32 The lid side is hinged on short i-motif staples that undergo conformational transition in response to lowered pH (from neutral), inducing the opening of the box (Table S2, Fig 1A   & S2) . Thus, unlike other locking systems including DNA lock-key clasps 33 and aptamerencoded logic gates, 34 this design does not require externally applied keys. Instead, the hinge regions switch conformations within a narrow pH range as a sufficient means to respond to acidic endosomal environments thereby facilitating the egress of encapsulated cargo (Fig 1A) . and open (pH 6) states in FRET spectra (B) and plotted versus time (C).
As gauged by electrophoretic and chromatographic measurements, the topology yielded a monodisperse assembly (Fig S4) . Further, circular dichroism (CD) absorption spectra revealed characteristic signal enhancements at 285 nm (B-form DNA) for individual i-motif strands with decreasing pH (Fig S5A) . These findings indicate a stabilized i-motif formation at pH <6, 35 and are in accord with electrophoretic measurements that revealed the disintegration of the assembly down to the scaffold strand at pH <5.6 (Fig S5B) . To monitor the lid opening, fluorescence resonance energy transfer (FRET) was measured using a pH-independent reporter-quencher pair incorporated into the lid (rhodamine G -reporter) and the lock face of the box (dabcyl -quencher) (Table S3, At neutral pH, in a closed state, the pair components are in close proximity to each other, at which the donor emission is effectively quenched. By contrast, lowering the pH to 6 sharply increases the emission of rhodamine G (535 nm), corresponding to the lid opening (Fig 1B, C) .
Further decreases in pH (<5.6) remove the lock strands, displaces the lid and open the box up (Fig S5C) , which agrees with the disintegration observed by the electrophoretic analysis ( Fig   S5B) . The results are characteristically consistent with the topography of the design, monitored by atomic force microscopy (AFM). 37 In a pre-folded state, which lacks the lock strands, the topology appeared as a ~60 nm sheet that was equal across all symmetry axes, while its thickness of 2 nm matched that of the DNA double helix (Fig 2) . In a fully assembled, closed, state, monodisperse, discrete cubes of 20-25 nm in diameter were apparent (Figs 2 and S5D).
In this assembled state the boxes remained stable in buffer under the experimental conditions of SEC and AFM imaging (Materials and Methods). Note should be taken that open origami designs tend to exhibit poor structural integrity in buffers containing low levels of divalent cations and therefore require protection (e.g. protein or peptide coating). 38, 39 Such protection also helps increase stability in diluted serum (e.g. 10% at 37 °C). 38 Encouragingly, when tested in 5% serum at 37 °C the designed boxes remained intact for several hours ( Fig S5E) .
Collectively, the data confirms the physicochemical properties of the topology, as designed, prompting its functional assessment for intracellular protein delivery.
Designed with dimensions allowing for the encapsulation of several copies of the same protein, the box was co-assembled with a green fluorescent protein (GFP) into a closed state at protein/DNA (P/N) molar ratios of 750 ( Fig 3A) . The ratios were sufficient to demonstrate GFP encapsulation driven by diffusion ( Fig S6A) , with at least one in every ten boxes expected 7 to encapsulate GFP. The protein has a suitable size (4 x 2.5 nm) and appreciable intrinsic fluorescence, which facilitates in the monitoring of encapsulation by fluorescence. Following purification by size-exclusion chromatography (SEC) to remove excess protein and excess single strands (Fig S6B) , fluorescent traces were recorded for boxes encapsulating GFP ( Fig   3B) . Strong fluorescence was observed for both GFP (515 nm) and Cy3 (550 nm) for the boxes that were assembled with GFP and closed, i.e. GFP-loaded closed boxes ( Fig S6C) , with Cy3 being a complementary fluorescent dye incorporated into the boxes to enable differential fluorescence for cell imaging. The traces obtained for the GFP-loaded closed boxes were in drastic contrast to those obtained for boxes that remained open during incubation with GFP ( Fig 3B) . Indeed, no fluorescence was observed at 515 nm, whereas Cy3 emission was comparable to that of the closed boxes (Fig 3B) . This data supports the encapsulation of GFP, suggesting also that a more effective means could be used to reach high levels of protein packaging, e.g. via specific protein recognition motifs recruited in the interior of the boxes.
To render the topology infectious, the boxes were non-covalently decorated with HIV-Tat transduction domains (Fig 3A) . 40, 41 As judged by dynamic light scattering measurements, at P/N (HIV-Tat to DNA) charge ratios of 1-6 the complexation led to marginal size increases without affecting the monodispersity of the assembly, with PDI values being typical of DNA origami, ~0.2 (Fig S7A) . No apparent aggregation was observed by AFM either (Fig S7B) .
Higher ratios gave no increase in complexation and no appreciable changes in the electrophoretic mobility of the boxes (Fig S7C) , suggesting that complexation was complete at lower P/N ratios. At the same lower ratios, as gauged by sigmoidal thermal denaturation curves, the assembly remained cooperative with a transition temperature of 56 °C, which in complex with the domains gave a net increase of over 4 °C in thermal stability (Fig S7D) .
Boxes functionalized at the lower ratios effectively transfected HeLa cells promoting GFP release into the cytoplasm (Fig 3C, D) . Particulate spreads of fluorescent DNA were apparent in the cytoplasm within the first hours of incubation suggesting an endocytic uptake (Fig S8 &   S9 ). The spreads were stable over 24 hours, so was the intracellular distribution of GFP ( and PCR measurements confirmed that HIV-Tat functionalized boxes effectively traversed cellular membranes and delivered GFP into the cytoplasm (Fig S11A-C) , while transfection efficiencies appeared to improve at higher P/N ratios (Fig S11C) .
To gain a better insight into the mechanistic uptake of the assembly, cells were incubated with
NH4Cl, that is commonly used to block endosomal acidification and escape. 40 No apparent differences in median GFP fluorescence versus that of control cells (NH4Cl-untreated) suggest that GFP-loaded HIV-Tat-functionalized boxes may remain trapped in endosomes or enter cells via a non-endocytic pathway (Fig S11E) . To clarify this further, transfections were treated with bafilomycin A1 (Baf A1) -an antibiotic that arrests the endocytic uptake while inhibiting endosomal acidification. Baf A1 is a specific inhibitor of vacuolar ATPase proton pumps regulating sub-membranous pH and the formation of macropinosomes. 42 The antibiotic caused up to 70% reductions in the uptake of the complex compared to the control incubations, indicating that endosomal uptake and escape were inhibited (Fig S11E) . Together with the particulate spreads of fluorescent DNA and GFP observed by microscopy (Figs 3D, S8-S10) these results suggest that the designed topology favors an endocytic pathway to enter cells with likely a limited capacity to escape endosomes. Although the exact role of i-motif locks in the protein release is not completely clear, the mechanism of intracellular delivery is consistent with other DNA-origami topologies considered for drug delivery. 
Methods
Materials. Native and modified DNA (0.1 or 1 μmol, desalted) were purchased from Integrated DNA Technologies (US). The modified DNA was purchased on a 1 μmol scale with HPLC or PAGE purification. The scaffold strand M13mp18 was procured from New England Biolabs (UK). GFP was expressed from an eGFP plasmid and purified by size exclusion chromatography. The HIV-Tat peptide was prepared as described elsewhere. 41 All other reagents and solvents were purchased from Sigma-Aldrich.
DNA design. The DNA origami was designed using CaDNAno software. 19 It was generated using a square lattice framework, with M13mp18 as a scaffold strand. The sequences and 2D map are shown in Tables S1-S3, while the staple layout is given in Fig S1, S2 . To insert the correct i-motif-forming sequence into the structure, the scaffold strand in the corresponding imotif region was formed from oligonucleotides separate from the M13mp18 scaffold (Table   S2 ).
Folding DNA origami. To prepare DNA constructs, the M13mp18 scaffold strand (120 µL, stock 100 nM, final concentration 12 nM) and a 10-fold excess of staple strands (150 µL, stock 390 nM, final concentration 58.5 nM), were added to PBS (10x) containing 140 mM MgCl2, pH 7.4 (100 µL) and deionized water (630 µL). DNA was folded by heating the solution to 70°C for 1 min and cooling to 5°C at a rate of 1°C/15 min using a PCR thermocycler. For FRET quenching studies, the rhodamine G and Dabcyl staples were added to the reaction mixture to a final concentration of 0.4 µM, each. For Cy3 labelled studies, the Cy3 staple was added to the reaction mixture to a final concentration of 1.2 µM. For GFP encapsulation studies, 11 300 µL of deionised water was replaced for GFP (300 µL, stock concentration 30 µM, final concentration of 9 µM, or stated otherwise). Note: the melting temperature of GFP is >70°C.
To assemble the open box state, the two i-motif forming sequences in Table S2 were omitted from the folding mixture.
Size exclusion liquid chromatography. The assembled DNA origami box was purified from excess staple strands using an ÄKTA purifier 100/10 fitted with a Superdex 200 10/300 GL column (GE Healthcare) using PBS as an elution buffer. The sample was injected in a 1 mL volume to a 1 mL loading tube, with a flow rate of 0.5 mL per min at 8 °C. The elution was monitored via UV-vis absorption at 260, 280, 488, 540 and 562 nm, wherever appropriate, and collected in a 96-well plate in 0.25 mL fractions. Fractions containing the folded DNA were pooled together, purified and the nanostructure was kept at 4°C and used within 24 hours.
DNA box concentration and the ratio to HIV-Tat.
The concentration of the purified box was determined using a FLUOstar Omega plate reader equipped with LVis Plate in µg/mL. For cell studies, HIV-Tat domains (stock 0.15 mM in Milli-Q water) were added in a 400-fold excess to the purified DNA box.
Agarose gel electrophoresis. The assembly products were analysed using a 1.5% agarose gel electrophoresis in Tris-acetate-EDTA (TEA) buffer (1 x). DNA samples (10-20 µL) were mixed with an SDS-free gel (6 x) loading buffer (5 µL, New England Biolabs) and loaded into the wells. The gels were run at 70 V for 1 h at 8°C. A 1000-base-pair marker (New England Biolabs) was used as a reference standard, unless stated otherwise. DNA bands were visualized by ultraviolet after staining with ethidium bromide solution. For stability analysis in serum, the purified DNA box was incubated at 37 °C with 5% fetal bovine serum. 20 µL samples were extracted at the time points stated, 5µL of gel loading dye was added and the solution was cooled on ice until the final time point was collected, after which all the fractions were analysed by agarose gel electrophoresis. For complexes with HIV-Tat, 20 µL of the purified box was added to Tat (0.1-2 µL) and equilibrated for 10 mins at room temperature. After this, the gel loading dye (5 µL) was added and the gel was performed.
Circular dichroism and ultraviolet spectroscopy. CD spectra were recorded on a Chirascan
Plus spectropolarimeter (Applied Photophysics Ltd.) equipped with a Peltier temperature controller. All measurements were taken in millidegrees using a 1 nm step, 1 nm bandwidth, 0.5 second time/point, 2 acquisitions, and were recorded in a quartz cuvette with a 10 mm pathlength. The folding of staples forming i-motifs were monitored at 4.7 µM (total 250 µL in PBS, 1 x) containing 14 mM MgCl2 at pH 7.4 and room temperature. HCl was added in 0.1 µL fractions, and the pH was determined by a small-volume pH meter (Mettler Toledo).
Thermal denaturing studies were performed for the purified box encapsulating GFP (100 µL, Dynamic light scattering. DLS analysis was carried out on a Zetasizer Nano (ZEN3600, Malvern Instruments, UK) at 25°C using a 100 μL disposable cuvette. The purified DNA box containing GFP (100 µL, 19 µg/mL, abs260 nm = 0.38) was analyzed before and after the addition of HIV-Tat (0.8 µL, final concentration of 1.2 µM). The sample was allowed to thermally equilibrate for 10 minutes at 25°C, then scanned 7 times, each scan averaged and repeated 4 times. Hydrodynamic radii were obtained by fitting autocorrelation data to a single exponential function using the manufacture's Dispersion Technology Software (DTS version 5.10).
Fluorescence spectroscopy. A Varian Eclipse fluorescence spectrometer (Agilent, UK) was used to monitor the closed and opened states of the assembled box using a quartz cuvette with a path length of 1 cm. Excitation at 505 nm (10 mm slit width) and emission at 530 nm (5 nm slit width) were used with an average time/data point of 0.1 second, and a PMT voltage of 600.
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Rhodamine G and dabcyl staple strands were used (150 µL, 17.5 µg per mL, abs260 nm = 0.35).
HCl was added in 0.1 µL fractions and the solution rapidly was mixed. pH was determined using a small volume pH meter in a separate control assay. To determine the presence of GFP inside the purified box labelled with Cy3 (100 µL, 19 µg/mL, abs260 nm = 0.38), excitation was performed at 490 nm (GFP), and the emission scan range was 505-600 nm (Fig 3B) . 
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